Psychiatric outpatient clinic for emerging psychological disorders (PREPP Program): validation of the frech version of CAARMS
Details
Serval ID
serval:BIB_956EDAFCCE81
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
Title
Psychiatric outpatient clinic for emerging psychological disorders (PREPP Program): validation of the frech version of CAARMS
ISBN
0920-9964
Publication state
Published
Issued date
2006
Peer-reviewed
Oui
Volume
86
Series
Schizophrenia Research
Pages
80
Language
english
Notes
SAPHIRID:62931
Abstract
Introduction: Our purpose was to validate the discriminative of the CAARMS in an Psychiatric outpatient clinic for emerging psychological disorders (PREPP Program).
Methods: The original version of the Comprehensive Assessment for At Risk Mental State was translated and back translated and submitted to the original authors. Then, we first compare three groups of subjects (patients referred as prodomal, n = 27, with first episode, n = 22 and a normal controls group n = 15). In a second step, 18−25 years old patients referring with emerging psychological disorders were consecutively explored and enrolled in a prospective study.
Results: We compared 'inclusion groups' to groups issued from the CAARMS. CAARMS readily distinguished the three contrasted group of subjected. 100% of controls and 75 of first episode patients were correctly classified and total scores were significantly different across the groups. In a second step, we explore 80 patients reffered as for a emerging psychological disorders (PREPP Program) were explored and compared regarding to CAARMS criteria for sociodemographic, cognitive and clinical characterisitics and substance abuse. There was no significant difference between the groups at inclusion for sociodemographic variables, including cannabis exposure; though regular use of cannabis was higher in patients reaching the "psychosis" threshold (P: 66%) compared to at risk (AR: 53%) and not at high risk subject (NAR: 33%). Psychopathological severy also differ in the three groups. Outcome is currenty under analysis.
Discussion: This paper reports for the first time on the validation of a French version of CAARMS and confirm its discriminative value.
Methods: The original version of the Comprehensive Assessment for At Risk Mental State was translated and back translated and submitted to the original authors. Then, we first compare three groups of subjects (patients referred as prodomal, n = 27, with first episode, n = 22 and a normal controls group n = 15). In a second step, 18−25 years old patients referring with emerging psychological disorders were consecutively explored and enrolled in a prospective study.
Results: We compared 'inclusion groups' to groups issued from the CAARMS. CAARMS readily distinguished the three contrasted group of subjected. 100% of controls and 75 of first episode patients were correctly classified and total scores were significantly different across the groups. In a second step, we explore 80 patients reffered as for a emerging psychological disorders (PREPP Program) were explored and compared regarding to CAARMS criteria for sociodemographic, cognitive and clinical characterisitics and substance abuse. There was no significant difference between the groups at inclusion for sociodemographic variables, including cannabis exposure; though regular use of cannabis was higher in patients reaching the "psychosis" threshold (P: 66%) compared to at risk (AR: 53%) and not at high risk subject (NAR: 33%). Psychopathological severy also differ in the three groups. Outcome is currenty under analysis.
Discussion: This paper reports for the first time on the validation of a French version of CAARMS and confirm its discriminative value.
Create date
10/03/2008 10:00
Last modification date
20/08/2019 14:57